Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo

BSE1193.7021.2 (+1.81 %)

PREV CLOSE ( ) 1172.50

OPEN PRICE ( ) 1171.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 12937

TODAY'S LOW / HIGH ( )1169.65 1199.40

52 WK LOW / HIGH ( )994.35 1364.95

NSE1195.1022.9 (+1.95 %)

PREV CLOSE( ) 1172.20

OPEN PRICE ( ) 1175.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1195.10 (1112)

VOLUME 670100

TODAY'S LOW / HIGH( ) 1170.40 1199.50

52 WK LOW / HIGH ( )1010 1356.2

Quarters

Select year

( in Million)

Particulars

Sep 2025

Jun 2025

Mar 2025

Dec 2024

Audited / UnAudited

UnAudited

Net Sales

82857

78681.4

83821.2

79785.2

Total Expenditure

66076

62651.1

65902

64005.4

PBIDT (Excl OI)

16781

16030.3

17919.2

15779.8

Other Income

1205.9

1053

1348.1

1572.9

Operating Profit

17986.9

17083.3

19267.3

17352.7

Interest

952.4

977.5

1150.2

1184.8

Exceptional Items

0.00

PBDT

17034.5

16105.8

18117.1

16167.9

Depreciation

4291.9

4057

4444.3

4185.3

Profit Before Tax

12742.6

12048.8

13672.8

11982.6

Tax

4277.9

3826

4322.6

3542.8

Provisions and contingencies

Profit After Tax

8464.69

8222.8

9350.2

8439.80

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

8464.69

8222.8

9350.2

8439.80

Minority Interest

3.2

5.5

6.4

2.4

Shares of Associates

16.6

19.2

-321.9

15.9

Other related items

Misc. Expenses Written off

Consolidated Net Profit

8484.5

8247.5

9034.7

8458.1

Equity Capital

580.8

Face Value (IN RS)

Reserves

Calculated EPS

14.60

14.20

15.55

14.56

Calculated EPS (Annualised)

58.43

56.80

62.22

58.25

No of Public Share Holdings

279852902

% of Public Share Holdings

48.18

PBIDTM% (Excl OI)

20.25

20.37

21.37

19.77

PBIDTM%

21.70

21.71

22.98

21.74

PBDTM%

20.55

20.46

21.61

20.26

PBTM%

15.37

15.31

16.31

15.01

PATM%

10.21

10.45

11.15

10.57

Notes

Risk Disclosures on Derivatives

Quarterly Results

AUROBINDO PHARMA LTD.